(Date:12/2/2009)...na, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceut...CR ), a leading pharmaceutical company,specializin... of branded,generic and proprietary pharmaceutical...have been included in China,s National Drug Reimbu... Ministry of Human Resources and Social,Security o...
(Date:12/2/2009).... 2 According to the National Inst...cans diagnosed with diabetes already have some sta... damage to the retina caused by leaky blood vessel...abetes and is one of the most feared diabetic comp...nts who,ve had diabetes for 10 years or more will ...
(Date:12/1/2009).... 1 Reportlinker.com announces tha... catalogue: ,, Industrial Enzymes - A Global M...0164431/Industrial-Enzymes---A-Global-Market-Repor...opoly with few strong players and a host of small ... competition and commoditization characterize the ...
(Date:12/1/2009)...y Leader Richard Gephardt Brings Together A-List f...ities for "Best and Brightest Forum on Medical In...swire-USNewswire/ -- Several of New Jersey,s most ... medicine and technology gathered today at the Lib...edical innovation in New Jersey, and throughout th...
Breaking Biology Technology:Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5...th of 211 Percent Highlights Company Transition to...YVALE, Calif., Feb. 28 Cepheid (Nasdaq:,CPHD) tod...ter and full,year ended December 31, 2007., Key ...s of $129.5 million, a 48 percent increase from ...- Total product sales of $116.5 million, a 41 perc...
...n milestone payment, WILMINGTON, N.C., Feb. 28 P...a Pharmaceutical Company Limited,s new drug,applic...-4 inhibitor for,the treatment of type 2 diabetes,... Drug Administration. PPD partnered with Takeda to...h Takeda, the FDA,s acceptance of the NDA,filing t...
...med New Controller --, MADISON, N.J., Feb. 28 Wy... John C. Kelly to Vice President and,Controller, W... Paul J.,Jones, who is retiring after a 30-year ca... and Controller for the past 13 years., Since joi...ange of,assignments in finance, most recently as V...
Other Biology Technology:Cepheid Reports Fourth Quarter and Full Year 2007 Results 2Cepheid Reports Fourth Quarter and Full Year 2007 Results 3Cepheid Reports Fourth Quarter and Full Year 2007 Results 4Cepheid Reports Fourth Quarter and Full Year 2007 Results 5Cepheid Reports Fourth Quarter and Full Year 2007 Results 6Cepheid Reports Fourth Quarter and Full Year 2007 Results 7Cepheid Reports Fourth Quarter and Full Year 2007 Results 8Cepheid Reports Fourth Quarter and Full Year 2007 Results 9Cepheid Reports Fourth Quarter and Full Year 2007 Results 10Cepheid Reports Fourth Quarter and Full Year 2007 Results 11Cepheid Reports Fourth Quarter and Full Year 2007 Results 12Cepheid Reports Fourth Quarter and Full Year 2007 Results 13Cepheid Reports Fourth Quarter and Full Year 2007 Results 14PPD Confirms Takeda's NDA Filing of Alogliptin with U.S. Food and Drug Administration 2Wyeth Announces Executive Change in Finance Organization 2PROTEAN II xi Cell, 16 cm, without spacers and combs from Bio-Rad
CleanCut Agarose, 2%, 12 ml from Bio-Rad
Safire 2 from Tecan
...h pressure dual piston pump and the Adept CE 4200 ... The system is provided with PowerStream data proc... CE 4901 PowerStream software operating in Windows...ers the same data processing power as the CE 4900 ...
Biology Products: